Skip to content

500NL project

500NL project - 500NL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON37251
Enrollment
1500
Registered
2013-05-01
Start date
2013-08-01
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Autoimmuunziekten Infectious diseases and autoimmune diseases

Interventions

None listed

Sponsors

Universitair Medisch Centrum Sint Radboud
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: healthy volunteers (n=500): - older than 18 years - no chronic or acute disease at the time of assessment - no use of chronic or acute medication at the time of the study Inclusion criteria for the patient groups:;RVVC patients (n=200) - healthy women, age >18 years - no pregnancy, no diabetes, no antibiotic use - at least 3 episodes of vulvo-vaginal candidiasis per year, microbiologically confirmed;Candidemia patients (n=50) - patient with blood culture positive for a Candida species - age > 18 years - treatment given no longer than 24h before sample collection;Lyme disease patients (n=150) - age > 18 years old - clinical diagnosis based on erythema migrans. - positive serology (IgG) for Borrelia. ;Gout patients (n=200) - age > 18 years - diagnosis based on clinical criteria and positive urate crystals in the joint fluid;HIV-infected patients (n=400) - age > 18 years - HIV infection based on viral loads and CD4 counts - no opportunistic infection at the time of sampling

Exclusion criteria

Exclusion criteria: Pregancy Age

Design outcomes

Primary

MeasureTime frame
Metadata: Lifestyle questionnaires DNA: Gene polymorphisms at DNA level Microbiome: Presence of groups of bacteria Phenotype: Specific populations of cells Functional data: Cytokine production

Secondary

MeasureTime frame
Niet van toepassing

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)